Switching Anti-TNF-Alpha Agents in Patients With RA With An Inadequate Response to TNF-Alpha Inhibition.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Adalimumab; Etanercept
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
Most Recent Events
- 04 Oct 2012 Biomarkers information updated
- 08 Nov 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 21 May 2010 Planned end date changed from 1 Sep 2010 to 1 Sep 2012 as reported by ClinicalTrials.gov.